Cargando…

A Systematic Review of Xuezhikang, an Extract from Red Yeast Rice, for Coronary Heart Disease Complicated by Dyslipidemia

Objective. This systematic review aims to evaluate the benefit and side effect of Xuezhikang for coronary heart disease (CHD) complicated by dyslipidemia. Methods. All randomized clinical trials (RCTs) with Xuezhikang as a treatment for CHD combined with dyslipidemia were considered for inclusion. D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shang, Qinghua, Liu, Zhaolan, Chen, Keji, Xu, Hao, Liu, Jianping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332166/ https://www.ncbi.nlm.nih.gov/pubmed/22567033 http://dx.doi.org/10.1155/2012/636547

Ejemplares similares

Comparison of the Reductions in LDL-C and Non-HDL-C Induced by the Red Yeast Rice Extract Xuezhikang Between Fasting and Non-fasting States in Patients With Coronary Heart Disease
por: Zhu, Li-Yuan, et al.
Publicado: (2021)

Xuezhikang, Extract of Red Yeast Rice, Improved Abnormal Hemorheology, Suppressed Caveolin-1 and Increased eNOS Expression in Atherosclerotic Rats
por: Zhu, Xin-Yuan, et al.
Publicado: (2013)

Oral Panax notoginseng Preparation for Coronary Heart Disease: A Systematic Review of Randomized Controlled Trials
por: Shang, Qinghua, et al.
Publicado: (2013)

Xuezhikang, an extract from red yeast rice, attenuates vulnerable plaque progression by suppressing endoplasmic reticulum stress-mediated apoptosis and inflammation
por: Shen, Linghong, et al.
Publicado: (2017)

Effects of Xuezhikang versus Pravastatin on Triglyceride Level in Patients with T2DM and Dyslipidemia: Study Protocol for a Multicenter Randomized Controlled Trial
por: Xu, Jin, et al.
Publicado: (2023)

A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia
por: Li, Yinhua, et al.
Publicado: (2014)

Effectiveness and safety of Linggui Zhugan decoction for the treatment of premature contraction in patients with coronary heart disease: A systematic review and meta-analysis
por: Liu, Longkun, et al.
Publicado: (2022)

Red Yeast Rice
por: Nguyen, Thu, et al.
Publicado: (2017)

Xuezhikang reduced arterial stiffness in patients with essential hypertension: a preliminary study
por: Zheng, J., et al.
Publicado: (2017)

Novel findings in relation to multiple anti-atherosclerotic effects of XueZhiKang in humans
por: Xu, Rui-Xia, et al.
Publicado: (2017)

Postmarketing nutrivigilance safety profile: a line of dietary food supplements containing red yeast rice for dyslipidemia
por: Banach, Maciej, et al.
Publicado: (2021)

New Cytotoxic Azaphilones from Monascus purpureus-Fermented Rice (Red Yeast Rice)
por: Li, Jin-Jie, et al.
Publicado: (2010)

Ultrasonic extraction, structural characterization, and antioxidant activity of oligosaccharides from red yeast rice
por: Liu, Kai, et al.
Publicado: (2021)

Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2014)

Effect of Xuezhikang Therapy on Expression of Pulmonary Hypertension Related miR-638 in Patients With Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2021)

Rhabdomyolysis Related to Red Yeast Rice Ingestion
por: Santos, Sara, et al.
Publicado: (2023)

Effect of a Monascus sp. Red Yeast Rice Extract on Germination of Bacterial Spores
por: Husakova, Marketa, et al.
Publicado: (2021)

ITIH4: A New Potential Biomarker of “Toxin Syndrome” in Coronary Heart Disease Patient Identified with Proteomic Method
por: Xu, Hao, et al.
Publicado: (2013)

Xuezhikang Capsule for Type 2 Diabetes with Hyperlipemia: A Systematic Review and Meta-Analysis of Randomized Clinical Trails
por: Li, Min, et al.
Publicado: (2015)

Red Rice Bran Extract Alleviates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease and Dyslipidemia in Mice
por: Munkong, Narongsuk, et al.
Publicado: (2023)

Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials
por: Liu, Jianping, et al.
Publicado: (2006)

Assessment of Extracts from Red Yeast Rice for Herb-Drug Interaction by in-vitro and in-vivo assays
por: Fung, Wai To, et al.
Publicado: (2012)

Scientific opinion on the safety of monacolins in red yeast rice
por: Younes, Maged, et al.
Publicado: (2018)

Complex Networks Approach for Analyzing the Correlation of Traditional Chinese Medicine Syndrome Evolvement and Cardiovascular Events in Patients with Stable Coronary Heart Disease
por: Gao, Zhuye, et al.
Publicado: (2015)

Mini-review: medication safety of red yeast rice products
por: Farkouh, André, et al.
Publicado: (2019)

Chinese red yeast rice (Monascus purpureus-fermented rice) promotes bone formation
por: Wong, Ricky WK, et al.
Publicado: (2008)

Interaction between Red Yeast Rice and CYP450 Enzymes/P-Glycoprotein and Its Implication for the Clinical Pharmacokinetics of Lovastatin
por: Chen, Chia-Hao, et al.
Publicado: (2012)

Dyslipidemia: A Trigger for Coronary Heart Disease in Romanian Patients with Diabetes
por: Găman, Mihnea-Alexandru, et al.
Publicado: (2020)

Red Yeast Rice Preparations Reduce Mortality, Major Cardiovascular Adverse Events, and Risk Factors for Metabolic Syndrome: A Systematic Review and Meta−analysis
por: Yuan, Rong, et al.
Publicado: (2022)

An alternative treatment of hyperlipidemia with red yeast rice: a case report
por: Lin, James S
Publicado: (2010)

Quality and Authenticity Control of Functional Red Yeast Rice—A Review
por: Song, Jiawen, et al.
Publicado: (2019)

Dietary Supplements Based on Red Yeast Rice—A Source of Citrinin?
por: Twarużek, Magdalena, et al.
Publicado: (2021)

In Vivo Hypocholesterolemic Effect of MARDI Fermented Red Yeast Rice Water Extract in High Cholesterol Diet Fed Mice
por: Yeap, Swee Keong, et al.
Publicado: (2014)

The Meridian Tropism and Classification of Red Yeast Rice Investigated by Monitoring Dermal Electrical Potential
por: Wang, Meng-Tian, et al.
Publicado: (2021)

Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway
por: Zhao, Shui-ping, et al.
Publicado: (2017)

Efficacy of red yeast rice extract on myocardial infarction patients with borderline hypercholesterolemia: A meta-analysis of randomized controlled trials
por: Sungthong, Bunleu, et al.
Publicado: (2020)

Rhabdomyolysis or Severe Acute Hepatitis Associated with the Use of Red Yeast Rice Extracts: an Update from the Adverse Event Reporting Systems
por: Banach, Maciej, et al.
Publicado: (2023)

Inhibition of vascular remodelling in a porcine coronary injury model by herbal extract XS0601
por: Xu, Hao, et al.
Publicado: (2006)

Telomerase Inhibitory Effects of Red Pigment Rubropunctatin and Statin Monacolin L Isolated from Red Yeast Rice
por: Xu, Baojun, et al.
Publicado: (2017)

Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study
por: Spigoni, Valentina, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nvvv8bq61dadbbehgkeq797fkf